http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016038235-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca79dd45db01898a1c13c975110324c9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00452
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-203
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-20
filingDate 2014-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbfbe03348870adc56a47ca5853fb53f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eae05a2810133c0773cde4e791810db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c91222cd93b3fb8c868f6e050cb3a26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_020597024a970c733b73558ad1f1e375
publicationDate 2016-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2016038235-A1
titleOfInvention Ingenol mebutate in combination with laser therapy for the treatment of hyperkeratotic skin lesions
abstract The invention relates to the treatment of actinic keratosis (AK) lesions using laser therapy followed by treatment with ingenol mebutate (e.g., PEP005 Gel).
priorityDate 2013-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013338226-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015335644-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226655435
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID38846
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID38846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23980

Total number of triples: 35.